Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Molecules (Basel, Switzerland)|April 28, 2023
Novel PD-L1-Targeted Phenyl-Pyrazolone Derivatives with Antioxidant PropertiesRomain Regnault, Frédérique Klupsch, Hassiba El-Bouazzati, et al.Bioorganic & Medicinal Chemistry Letters|May 26, 2026
Chlorophenylpyrazolone derivatives as novel PD-L1-targeted inhibitors of the PD-1/PD-L1 immune checkpointFrédérique Klupsch, Raphaël Le Biannic, Hassiba El Bouazzati, et al.European Journal of Medicinal Chemistry|September 12, 2021
Discovery of a cryptic site at the interface 2 of TEAD - Towards a new family of YAP/TAZ-TEAD inhibitorsManon Sturbaut, Fabrice Bailly, Mathilde Coevoet, et al.European Journal of Medicinal Chemistry|August 21, 2016
Slowing down fat digestion and absorption by an oxadiazolone inhibitor targeting selectively gastric lipolysisVanessa Point, Anais Bénarouche, Julie Zarrillo, et al.European Journal of Medicinal Chemistry|April 16, 2022
Pyrazolones as inhibitors of immune checkpoint blocking the PD-1/PD-L1 interactionRaphaël Le Biannic, Romain Magnez, Frédérique Klupsch, et al.Cancers|November 27, 2021
The EGF Domains of MUC4 Oncomucin Mediate HER2 Binding Affinity and Promote Pancreatic Cancer Cell TumorigenesisNicolas Stoup, Maxime Liberelle, Céline Schulz, et al.Cancers|May 9, 2018
Toward the Discovery of a Novel Class of YAP⁻TEAD Interaction Inhibitors by Virtual Screening Approach Targeting YAP⁻TEAD Protein⁻Protein InterfaceFloriane Gibault, Mathilde Coevoet, Manon Sturbaut, et al.Movement Disorders : Official Journal of the Movement Disorder Society|June 16, 2022
Functional Analyses of Two Novel LRRK2 Pathogenic Variants in Familial Parkinson's DiseaseIlda Coku, Eugénie Mutez, Sabiha Eddarkaoui, et al.Cells|March 25, 2022
A Phosphosite Mutant Approach on LRRK2 Links Phosphorylation and Dephosphorylation to Protective and Deleterious Markers, RespectivelyAntoine Marchand, Alessia Sarchione, Panagiotis S Athanasopoulos, et al.Journal of Experimental & Clinical Cancer Research : CR|March 29, 2022
Direct interaction of TrkA/CD44v3 is essential for NGF-promoted aggressiveness of breast cancer cellsSarah Trouvilliez, Julien Cicero, Romain Lévêque, et al.Pageof 3